Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C055506 |
4-(diethylamino)benzaldehyde |
4-(diethylamino)benzaldehyde inhibits the reaction [R 115866 results in decreased activity of CYP26B1 protein] | decreases activity|decreases reaction | 17164423
|
C019429 |
4-hydroxyretinoic acid |
4-hydroxyretinoic acid affects the expression of CYP26B1 mRNA | affects expression | 16054125
|
C002202 |
4-oxoretinoic acid |
4-oxoretinoic acid affects the expression of CYP26B1 mRNA | affects expression | 16054125
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of CYP26B1 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CYP26B1 mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
Arsenic results in increased expression of CYP26B1 mRNA | increases expression | 19654921
|
C095105 |
bexarotene |
bexarotene results in increased expression of CYP26B1 mRNA | increases expression | 17849452
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of CYP26B1 mRNA | increases expression | 16002434
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP26B1 mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in decreased expression of CYP26B1 mRNA | decreases expression | 19619570
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of CYP26B1 mRNA | decreases expression | 17557909
|
C011890 |
kojic acid |
kojic acid results in increased expression of CYP26B1 mRNA | increases expression | 16595896
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides inhibits the reaction [Tretinoin results in increased expression of CYP26B1 mRNA] | decreases reaction|increases expression | 17185629
|
C007350 |
nitrofen |
nitrofen results in decreased expression of CYP26B1 mRNA | decreases expression | 17203325
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of CYP26B1 mRNA | increases expression | 18158353
|
C406527 |
R 115866 |
4-(diethylamino)benzaldehyde inhibits the reaction [R 115866 results in decreased activity of CYP26B1 protein] | decreases activity|decreases reaction | 17164423
|
C406527 |
R 115866 |
R 115866 results in decreased activity of CYP26B1 protein | decreases activity | 17164423
|
C406527 |
R 115866 |
[R 115866 co-treated with Vitamin A] results in increased expression of CYP26B1 mRNA | affects cotreatment|increases expression | 17510468
|
C406527 |
R 115866 |
[R 115866 results in decreased activity of CYP26B1 protein] which results in increased abundance of Tretinoin | decreases activity|increases abundance | 17510468
|
C406527 |
R 115866 |
R 115866 results in increased expression of CYP26B1 mRNA | increases expression | 17510468
|
C450682 |
R116010 |
R116010 promotes the reaction [Isotretinoin results in increased expression of CYP26B1 mRNA] | increases expression|increases reaction | 17486130
|
C450682 |
R116010 |
R116010 promotes the reaction [Tretinoin results in increased expression of CYP26B1 mRNA] | increases expression|increases reaction | 17486130
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in decreased expression of CYP26B1 mRNA | affects cotreatment|decreases expression | 19059307
|
D015474 |
Isotretinoin |
Isotretinoin results in increased expression of CYP26B1 mRNA | increases expression | 17486130
|
D015474 |
Isotretinoin |
R116010 promotes the reaction [Isotretinoin results in increased expression of CYP26B1 mRNA] | increases expression|increases reaction | 17486130
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in decreased expression of CYP26B1 mRNA | affects cotreatment|decreases expression | 19059307
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CYP26B1 mRNA | decreases expression | 16443690
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP26B1 mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CYP26B1 mRNA | decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CYP26B1 mRNA | increases expression | 19490992
|
D014050 |
Toluene |
Toluene affects the expression of CYP26B1 mRNA | affects expression | 18653662
|
D014212 |
Tretinoin |
Tretinoin affects the expression of CYP26B1 mRNA | affects expression | 16054125
|
D014212 |
Tretinoin |
Tretinoin affects the expression of CYP26B1 mRNA | affects expression | 17164423
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CYP26B1 mRNA | increases expression | 18230668
|
D014212 |
Tretinoin |
CYP26B1 protein affects the degradation of Tretinoin | affects degradation | 16574820
|
D014212 |
Tretinoin |
CYP26B1 protein results in increased metabolism of Tretinoin | increases metabolic processing | 17486130
|
D014212 |
Tretinoin |
R116010 promotes the reaction [Tretinoin results in increased expression of CYP26B1 mRNA] | increases expression|increases reaction | 17486130
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CYP26B1 mRNA | increases expression | 17431108 17486130
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CYP26B1 mRNA | increases expression | 16688765
|
D014212 |
Tretinoin |
Lipopolysaccharides inhibits the reaction [Tretinoin results in increased expression of CYP26B1 mRNA] | decreases reaction|increases expression | 17185629
|
D014212 |
Tretinoin |
[R 115866 results in decreased activity of CYP26B1 protein] which results in increased abundance of Tretinoin | decreases activity|increases abundance | 17510468
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CYP26B1 mRNA | increases expression | 17185629 17510468
|
D014212 |
Tretinoin |
CYP26B1 protein results in increased degradation of Tretinoin | increases degradation | 17510468
|
D014212 |
Tretinoin |
CYP26B1 protein results in increased metabolism of and results in decreased activity of Tretinoin | decreases activity|increases metabolic processing | 16933217
|
C017963 |
vinyl carbamate |
vinyl carbamate results in decreased expression of CYP26B1 mRNA | decreases expression | 17849452
|
D014801 |
Vitamin A |
[R 115866 co-treated with Vitamin A] results in increased expression of CYP26B1 mRNA | affects cotreatment|increases expression | 17510468
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.38 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Isotretinoin |
8.12 | 18769834 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.12 | 11752688 15322242 14514962 |
MESH:D000015 |
Abnormalities, Multiple |
|
Isotretinoin |
10.24 | 18769834 |
MESH:D000015 |
Abnormalities, Multiple |
|
Vitamin A |
10.24 | 10992263 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.39 | 18287403 |
MESH:D017486 |
Acneiform Eruptions |
|
Isotretinoin |
6.11 | 16232082 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
11.42 | 17505938 |
MESH:D000152 |
Acne Vulgaris |
|
Isotretinoin |
11.42 | 18769834 16185265 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
3.87 | 18653653 11850527 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
7.00 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
7.00 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
vinyl carbamate |
7.00 | 16247444 17363558 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.11 | 16835633 |
MESH:D018248 |
Adenoma, Liver Cell |
|
vinyl carbamate |
10.11 | 12371669 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.04 | 17306315 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.43 | 17308373 17451421 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.48 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.50 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.48 | 11748828 |
MESH:D000740 |
Anemia |
|
Vitamin A |
8.48 | 16960172 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Vitamin A |
4.65 | 16960172 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.67 | 10982225 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.96 | 17460149 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.82 | 12569548 18414634 16251483 16835338 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.29 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.86 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.86 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.23 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
5.04 | 16456186 |
MESH:D001249 |
Asthma |
|
Vitamin A |
5.04 | 16732791 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.15 | 12928151 19371607 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.43 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.24 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.42 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.42 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.62 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.65 | 15746008 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.37 | 15306635 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.30 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
3.66 | 16344269 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
3.66 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.66 | 12948864 16675129 17289903 17261762 18497071 14630087 19861407 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
3.66 | 17440819 17893378 16837676 15775269 17595753 15572757 17049068 15758505 17952589 16912660 17261762 17242785 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
3.66 | 16273361 20135344 16818667 15565566 17049068 19142967 19103187 19221464 18855134 18629630 16873071 19155303 19410462 20544844 20859285 19189210 18997820 19189212 18984771 16202921 18351453 19115204 20005174 11161223 19289846 17893378 19059307 18815881 18821012 19084267 21138602 21152245 19066611 19011961 17440819 19288272 17242785 17261762 20065188 20390343 18425577 15668708 19487384 19200415 19244106 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.66 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
3.66 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
12.44 | 16813970 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Vitamin A |
12.44 | 17377406 17426644 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.29 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.66 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.50 | 15504454 17687452 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.34 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.99 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
11.03 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
11.03 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
11.03 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
11.03 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
11.03 | 1917145 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
vinyl carbamate |
11.03 | 12371669 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
6.10 | 16247446 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
vinyl carbamate |
6.10 | 16247446 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
10.47 | 18922899 17687452 15504454 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
10.47 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Isotretinoin |
10.47 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
10.47 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
15.05 | 18640142 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
15.05 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
15.05 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
6.57 | 17124262 11179087 11754973 17287366 15728586 16170337 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.57 | 18850075 16120746 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
7.16 | 17938729 15738583 19152805 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
7.16 | 15775269 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.16 | 18022660 16973168 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.89 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.89 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.66 | 18566989 |
MESH:D002547 |
Cerebral Palsy |
|
Toluene |
5.68 | 9294310 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.42 | 16129372 |
MESH:D015362 |
Child Nutrition Disorders |
|
Vitamin A |
5.30 | 16153327 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.86 | 17681005 15861022 16919318 17333356 11677210 17110522 16105132 |
MESH:D002779 |
Cholestasis |
|
Vitamin A |
7.86 | 16175620 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.99 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
9.50 | 8697196 15668235 12621046 16354765 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
9.50 | 9407595 |
MESH:D002972 |
Cleft Palate |
|
Vitamin A |
9.50 | 16054864 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.45 | 15800139 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.53 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Vitamin A |
3.01 | 16267017 17219422 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.91 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Isotretinoin |
9.25 | 18769834 9879862 |
MESH:D019465 |
Craniofacial Abnormalities |
|
nitrofen |
9.25 | 11405365 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
9.25 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Toluene |
9.25 | 9294310 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
9.25 | 9142499 10589399 9211117 8800419 16925845 17551590 9224671 9125849 14991402 9664655 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin A |
9.25 | 10992263 |
MESH:D003643 |
Death |
|
Toluene |
5.49 | 6431079 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.19 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.02 | 17474826 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Vitamin A |
3.46 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.63 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
14.18 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
14.18 | 17308373 17451421 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
14.18 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
3.39 | 10774834 19416960 15619225 11834606 19164858 16227642 12594235 16109766 19923254 14986274 18713872 10915739 11743745 12705907 19420014 12958197 12392966 17522070 16485898 11421492 2444490 11461765 17562736 18071297 16393943 17906064 11739529 11287661 16177239 10663392 19085960 14550746 19370779 11529661 15968718 16781746 16081117 19739265 12540782 14725611 12153990 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.39 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.93 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.63 | 11462148 |
MESH:D015352 |
Dry Eye Syndromes |
|
Vitamin A |
5.63 | 16146918 |
MESH:C538011 |
Eales disease |
|
Vitamin A |
5.45 | 9068938 |
MESH:D004480 |
Ectromelia |
|
Vitamin A |
5.65 | 16054864 |
MESH:D004487 |
Edema |
|
Raloxifene |
6.34 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.34 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.37 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.37 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
20.57 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
20.57 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
20.57 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
20.57 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
11.78 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
11.78 | 16202921 19155303 17893378 20544844 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
11.78 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.87 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.22 | 17637181 15821434 15328337 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.41 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.41 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
12.25 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
12.25 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
12.25 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.13 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.29 | 11858732 |
MESH:D005327 |
Fetal Resorption |
|
Vitamin A |
5.19 | 16054864 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.86 | 11852909 9205823 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.35 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.01 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.05 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.05 | 17994277 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.39 | 6392382 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.50 | 16983495 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.90 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.42 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.07 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.99 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
nitrofen |
15.35 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
15.35 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
15.35 | 14991402 9664655 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin A |
15.35 | 10992263 16080930 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.42 | 11110106 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.23 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.18 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.72 | 15340226 16120746 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
nitrofen |
6.43 | 15707848 9859898 15088113 7520565 11685700 11409163 12194112 16720372 15136996 11584395 17270546 9698600 7760232 17618886 10370017 15756563 17245593 12759764 9575882 11051153 16490937 18280292 10898222 18958481 8863223 10370016 11076806 10541330 15793718 12904592 12505043 11329586 18280291 15578192 9476886 10693666 10359170 11057544 10646786 12407540 7576705 10898224 15764645 12021965 16863852 15185205 16292651 16473863 16080930 11588001 12547725 9473106 12746050 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin A |
6.43 | 15707848 17436238 16877224 16490937 16863852 16292552 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.86 | 15709030 |
MESH:D015658 |
HIV Infections |
|
Vitamin A |
3.73 | 16960176 |
MESH:D006679 |
HIV Seropositivity |
|
Vitamin A |
5.43 | 17209195 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.58 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.87 | 15340226 18606429 16354765 16959395 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.17 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.17 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.40 | 16778211 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.30 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
11.89 | 16076760 11953799 9931084 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
11.89 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
11.89 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
11.89 | 18670907 18850075 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.40 | 12791704 18502941 |
MESH:D006986 |
Hypervitaminosis A |
|
Vitamin A |
6.00 | 16054864 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.39 | 16093927 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.64 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.30 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.37 | 17937319 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
7.82 | 17963957 9205823 17255318 12878042 17237260 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
7.82 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.82 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.86 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.60 | 17994277 |
MESH:D019586 |
Intracranial Hypertension |
|
Vitamin A |
5.65 | 15955940 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.47 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.41 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.41 | 15992940 17551590 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.82 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.56 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.56 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.92 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
6.92 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.33 | 16973256 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.69 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.54 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.05 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
7.39 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.39 | 9834237 17506722 17107899 16140955 17294898 17368321 17339181 19225113 16823087 19035177 16788101 17301526 17649720 19642359 17712046 16935935 17361223 16331271 12679006 17217047 19075265 19029980 16891316 16766008 15748426 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.53 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
8.10 | 9224671 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Vitamin A |
8.10 | 16054864 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.03 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Vitamin A |
3.78 | 16256175 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
8.46 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
8.46 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
8.46 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.46 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
8.46 | 18397230 16248980 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin A |
8.46 | 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.41 | 12969438 11587558 19014921 12587719 19784758 16610002 19460945 16611625 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
6.41 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Vitamin A |
6.41 | 16175620 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Vitamin A |
4.98 | 16762690 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.08 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
7.07 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.07 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.07 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
kojic acid |
9.42 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.42 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Vitamin A |
9.42 | 17113696 |
MESH:D008171 |
Lung Diseases |
|
nitrofen |
7.85 | 17245593 16863852 9614859 9859898 |
MESH:D008171 |
Lung Diseases |
|
Vitamin A |
7.85 | 16863852 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.84 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
8.30 | 17306315 17976673 19168569 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
8.30 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Isotretinoin |
8.30 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
8.30 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.30 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
vinyl carbamate |
8.30 | 12438228 17163412 11134547 12117777 15172992 15824018 17361011 17363558 16247444 12765245 11195469 14755239 16885199 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
4.98 | 11161223 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.59 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
9.41 | 19196723 15591091 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.41 | 17203775 11807958 11408345 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
9.41 | 14580682 19196723 11731420 19196722 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
12.07 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
12.07 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.72 | 17453147 |
MESH:D008545 |
Melanoma |
|
Isotretinoin |
5.05 | 17237267 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.05 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.05 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.01 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.40 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.25 | 16940565 |
MESH:D008607 |
Mental Retardation |
|
Toluene |
3.59 | 9294310 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.38 | 15863610 |
MESH:D019957 |
Motor Skills Disorders |
|
Toluene |
5.07 | 9294310 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
7.36 | 16497877 |
MESH:D009101 |
Multiple Myeloma |
|
Vitamin A |
7.36 | 16374440 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.98 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
8.55 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.55 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.15 | 16810080 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.38 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.48 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.46 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.33 | 16594593 16946489 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
10.36 | 19196722 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
10.36 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.56 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.37 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.37 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
15.37 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
11.68 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
11.68 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Vitamin A |
11.68 | 17400914 |
MESH:D009447 |
Neuroblastoma |
|
Isotretinoin |
3.96 | 17368321 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.73 | 18514411 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.21 | 17056641 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.29 | 17882678 19059307 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.07 | 15579764 15758505 17823083 17893378 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
7.60 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.60 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.60 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.13 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.13 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.40 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.53 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.08 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.01 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.82 | 6392382 16905509 15371236 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.38 | 11605937 12224865 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.39 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Isotretinoin |
9.28 | 18769834 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.28 | 11896295 11222880 11118676 11399792 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.61 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.73 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
1.88 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
1.88 | 15754350 18247401 16289102 12479363 16644109 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.88 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
1.88 | 16536755 15731164 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.88 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
8.74 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
8.74 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.14 | 15861022 16919318 |
MESH:D011596 |
Psychomotor Disorders |
|
Isotretinoin |
5.75 | 18769834 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.62 | 16723453 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.38 | 15770314 |
MESH:D012127 |
Respiratory Distress Syndrome, Newborn |
|
Vitamin A |
5.63 | 16877224 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.62 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.67 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.94 | 16116481 16283617 |
MESH:D012640 |
Seizures |
|
Toluene |
3.61 | 6431079 9294310 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.53 | 7327846 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
5.23 | 16759981 17453740 6392382 17548696 19834688 16353154 16702368 15952646 17050553 18709164 17938729 |
MESH:D012871 |
Skin Diseases |
|
Vitamin A |
5.23 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
9.01 | 17050553 17976673 16251483 19538983 17029826 15504454 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.01 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.01 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.98 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.98 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.87 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.79 | 17261132 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.69 | 16837676 |
MESH:D013733 |
Testicular Diseases |
|
Toluene |
4.78 | 10514026 10048760 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.01 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.46 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.01 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.73 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
2.90 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
13.14 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
13.14 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.64 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.12 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
8.04 | 17306315 18640142 19322015 17976673 11144890 19429237 15987713 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
8.04 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.04 | 8653321 16712894 17572228 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.82 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.53 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.13 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.44 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.56 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.42 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.04 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.38 | 14671159 15869587 |
MESH:D014802 |
Vitamin A Deficiency |
|
Vitamin A |
5.12 | 16960172 16146918 16175781 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.89 | 16761959 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.38 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.08 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.82 | 16287080 |